GO
Loading...

Corporate Leaders

More

  • When you're stressed, do you hit the bar or hit the gym? Do you drink whiskey or wheatgrass? Lululemon Athletica's incoming CEO Christine Day says that one strategic advantage of the high-priced yoga wear line is that during an economic downturn, people choose things to relieve that stress--like working out.

  • Amgen's Bone Drug Data: Is There "Bone Of Contention"? Thursday, 3 Apr 2008 | 11:05 AM ET
    AMGEN

    After the closing bell yesterday, Amgen put out a press release announcing that phase 3 pivotal data are being published in a scientific/medical journal about its most important drug development pipeline product--an osteoporosis drug known as D-mab. (Whenever you see the letters mab at the end of the scientific name for a drug it means it's a monoclonal antibody).

  • Arch's Coal Is Already Clean Wednesday, 2 Apr 2008 | 7:08 PM ET

    Forget ethanol – this company’s got an alternative for the alternative.

  • Is Medco Healthy? Tuesday, 1 Apr 2008 | 6:52 PM ET

    Cramer went right to the source to find out. Let the CEO explain.

  • Vytorin Battle Pits Merck/Schering-Plough Vs Pfizer Tuesday, 1 Apr 2008 | 11:03 AM ET

    Given investor reaction to the Vytorin/Zetia news yesterday, you might draw the conclusion the huge cholesterol drug franchise might be doomed. Sure, analysts say, prescriptions and sales are gonna go down some more, but they're not going to zero.

  • Schering CEO Speaks on Vytorin Monday, 31 Mar 2008 | 6:59 PM ET

    "We stand behind our product," Fred Hassan says. But does Cramer?

  • Where There's a Willbros, There's a Way Friday, 28 Mar 2008 | 6:49 PM ET

    The CEO of the engineering company tells Cramer what he's doing to dominate the oil and gas market.

  • When I heard a soundbite with Sen. Hillary Clinton on CNBC's "Kudlow & Company" last night, it reminded me to check and see if the Center for Responsive Politics had updated its monthly campaign contribution data.

  • Ex-Bear Exec Can't Join Morgan Stanley: Judge Friday, 28 Mar 2008 | 7:03 AM ET

    A U.S. federal judge has temporarily blocked a former senior Bear Stearns executive from jumping to Morgan Stanley and recruiting clients and colleagues to follow him.

  • Countrywide Financial

    Bank of America said it has agreed to pay $28 million to Countrywide Financial Chief Operating Officer David Sambol to induce him to run the merged companies' consumer mortgage operations.

  • Biovail's Travails Drag "60 Minutes" Into Controversy Thursday, 27 Mar 2008 | 4:09 PM ET
    BIOVAIL

    The Columbia Journalism Review, the pre-eminent publication and authority on what we in the business refer to as "The Big J"--as in Journalism--is calling out CBS' "60 Minutes" in an article just posted on the web with the somewhat explosive headline, "60 Minutes Blows Biovail Story."

  • General Mills CEO: Food Inflation Will 'Moderate' Thursday, 27 Mar 2008 | 3:42 PM ET

    But a global economic boom will keep at least some prices up.

  • Buy U.S. Steel Wednesday, 26 Mar 2008 | 7:22 PM ET

    While the rest of the sector was going bankrupt, this company thrived. No wonder it's Cramer's favorite in the group.

  • Bogle: Stock Returns Will Stay 'Subdued' for Years Wednesday, 26 Mar 2008 | 2:54 PM ET

    Vanguard founder and former CEO John Bogle told CNBC that he expects the stock market's meager returns to continue for some time. "Be mentally prepared for some pretty slovenly going--some subdued returns--for quite a few years," Bogle said.

  • Bear Stearns' Amgen Call  Brings On More Gallows Humor Wednesday, 26 Mar 2008 | 1:16 PM ET

    This morning, Bear Stearns biotech analyst Mark Schoenebaum and a couple of members of his research team hosted a conference call with a 50-page PowerPoint about Amgen. The purpose was to drill down into the looming court decision over whether Roche will be able to launch a competing anemia drug in the U.S. for kidney dialysis patients.

  • Big Pharma Power Shift: CFOs May Have The Mojo Now Wednesday, 26 Mar 2008 | 11:01 AM ET

    Big pharma CEOs might wanna watch their backs because there could be a burgeoning power struggle in the C-suite. Ernst & Young, which has a long history of doing comprehensive reports on the pharmaceutical and biotech industries, is out with a new one today declaring that it's big pharma Chief Financial Officers who have all the mojo these days.

  • Anadarko CEO: 'Ethanol Didn't Work' Tuesday, 25 Mar 2008 | 7:01 PM ET

    Government favor of the corn-based alternative fuel was a big mistake, he says. Here's how to avoid repeating it.

  • J&J, Merck & Wyeth Tops in Big Pharma CEO Pay Tuesday, 25 Mar 2008 | 11:31 AM ET

    As proxy statements pop up on www.sec.gov, investors can get a peek at who's making what. When you go to the web site, click on "Search for company filings," then click on "Companies and other filers," enter the ticker symbol, click on "Find companies" and then open up the "14A" or proxy statement.

  • Buy Costco Monday, 24 Mar 2008 | 7:46 PM ET

    With CEO Jim Sinegal predicting the company will double its size in ten years, it's no surprise Cramer said this is "the best retailer in America."

  • Biovail's Travails And The "Haunting" Truck Accident Monday, 24 Mar 2008 | 4:12 PM ET
    BIOVAIL

    Shares of Canada's biggest biotech initially hit a new intra-day low this morning of 10 bucks a share this morning, but rallied into the close as investors seem to like the fact that the company may have extricated itself from allegations of financial fraud.

Most Popular Video

Wednesday, 23 Apr 2014 | 4:57 PM ET

Weekly jobless claims and durable goods are the numbers to watch Thursday, but so are the massive amount of earnings reports expected. CNBC's Patti Domm explains.

Wednesday, 23 Apr 2014 | 4:32 PM ET

Apple is reporting Q2 EPS of $11.62 on revenue of $45.6 billion. Gene Munster, Piper Jaffray senior research analyst, says investors should feel a sense of relief on these numbers.

Wednesday, 23 Apr 2014 | 3:23 PM ET

CNBC's Becky Quick discusses Warren Buffett's feelings about the market.